In order to operate the site and better serve you, we collect your data. We also use this data and share with our vendors for the purposes of marketing, research, and monitoring.
Overview Abecma is a therapy approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory multiple myeloma after four or more prior therapies, including an immunomodulatory agent,… read more
Join